Jason Joel Emer, MD Present Work Address and Contact

Spalding Drive Plastic Surgery and Cosmetic Dermatology 120 S. Spalding Drive, Suite 315

Beverly Hills, CA 90212 E-mail: Jason.EmerMD@gmail.com

Office Phone: (310) 275-2467 Education Cosmetic Dermatology and Laser Fellowship, University of California San Francisco, San Francisco, California (non-ACGME) 1701 Divisadero Street, San Francisco, California, 94115 Phone: (415) 353-7800

July 2013 – December 2013 Fellow Dermatology Residency, Mt. Sinai Hospital, New York, New York 5 East 98th Street, 5th Floor, New York, New York, 10029 Phone: (212) 241-9728

July 2010 – June 2013 Chief Resident

Dermatopharmacology Research Fellow, Mt. Sinai Hospital, New York, New York 5 East 98th Street, 5th Floor, New York, New York, 10029 Phone: (212) 241-9728

July 2008 – June 2010 PGY 1, Internship in Preliminary Medicine, St. Joseph Hospital, Chicago, Illinois 2900 North Lake Shore Drive, Chicago, Illinois, 60657 Phone: (773) 665-3000 / (773) 665-3017

June 2007 – June 2008 M.D., University of Illinois at Chicago College of Medicine, Chicago, Illinois

1853 West Polk Street, Chicago, Illionis, 60612 Phone: (312) 996-3500 August 2003 – May 2007

• USMLE Step 1: Passed (6/10/2005) • USMLE Step 2 CK: Passed (2/5/2007) • USMLE Step 2 CS: Passed (12/12/2006) • USMLE Step 3: Passed (6/26/2008) • Honor Grades: Medical Nutrition, Pathology, Surgery, Psychiatry, Family

Medicine, Dermatology B.S., University of Illinois at Champaign-Urbana, Champaign, Illinois 901 West Illionis Street, Urbana, Illinois, 61801 Phone: (217) 333-0302 Major/Minor: Honors Biology/Chemistry

August 1999 – May 2003 Certification Diplomate of the American Board of Dermatology, a Founding Member of the American Board of Medical Specialties on 9/12/2013 Licensure New York State Medical License # 250356, issued 9/15/2008, expiration 11/30/2015 DEA, issued 8/7/2011, expiration 8/31/2017 California State Medial License #A123791, issued 12/5/2012, expiration 12/31/2014 Undergraduate Awards & Membership in Honorary/Professional Societies

• Arrie and Estelle Johnson Bamberger Scholarship (financial assistance based on academic performance)

• Phi Beta Kappa Junior Inductee • National Society of Collegiate Scholars • Golden Key International Honor Society • James Scholar for College of Liberal Arts and Sciences • Magna Cum Laude Graduate at University of Illinois at Champaign-Urbana

Undergraduate Work Experience

• UIC College of Medicine Teaching Assistant for Medical Nutrition and Biochemistry Courses

• UIC College of Medicine Basic Science Review Lecturer • University of Illinois Teaching Assistant in the Department of Chemistry

(Biochemistry, General Chemistry, Organic Chemistry) • University of Illinois Merit Section Teaching Assistant in the Department of

Chemistry (Organic Chemistry) • University of Illinois Supplemental Instruction Student Leader (Organic

Chemistry)

Undergraduate Volunteer Experience • Undergraduate and Medical Student Research Assistant for Dean M. Toriumi,

Associate Professor in Department of Otolaryngology at University of Illinois at Chicago

• Medical Student Volunteer at the UIC Nutrition and Wellness Center • Surgical Assistant for Dr. Jonathan S. Bailey, Carle Hospital, Division of Oral and

Maxillofacial Surgery • Judiciary Board Member for the Office of Student Conflict Resolution and the

Interfraternity Council at the University of Illinois

Graduate Awards and Honors • Editor and Contributing author for Cosmetic Surgery Times, beginning June

2014. (http://cosmeticsurgerytimes.modernmedicine.com/authorDetails/384072) • Voted a San Francisco “Beauty Guru” by Beauty in the Bag, March 2014.

(http://www.beautyinthebag.com/wordpress/meet-san-francisco-dermatologist-jason-emer-md/)

• Section Editor, “Dilemmas in Derm,” Journal of Clinical and Aesthetic Dermatology, beginning July 2012.

• Associate Faculty Filler and Toxin Master Workshop, ASDS Annual Meeting, Atlanta, Georgia, Oct 11-14, 2012.

• ASDS Preceptorship Program Award Reciepient. June 2012. (http://www.asds.net/ASDSPreceptorshipProgram.aspx)

• Practical Dermatology Journal Resident Advisor, beginning May 2012. • Third Prize at the Dermatologic Society of Greater New York Resident

Competition, Lennox Hill, New York, Jan 26, 2012 for a study titled: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Ammonium Lactate Lotion 12% (Lac-Hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis.

• Faculty, Winter Clinical Dermatology Conference, Jan 14-19, 2012, Hyatt Regency Maui, Hawaii.

• Faculty, Fall Clinical Dermatology Conference, Oct 27-30, 2011, Caesars Palace, Las Vegas, Nevada.

• Allure.com beauty product expert, beginning October 2011. (http://www.allure.com/beauty-products/beauty-product-finder/experts/dermatologist-jason-emer)

• Resident Research and Education Grant from CoverFX Cosmetiscs, announced Nov 5, 2010 at the Mount Sinai School of Medicine Grand Rounds Meeting.

• First Prize at the Resident’s Competition at the Winter Clinical Dermatology Conference, Grand Hyatt Kauai, Hawaii, Jan 23-28, 2010 for study titled: A Randomized, Double-Blind Study to Evaluate the Efficacy of Ammonium Lactate Lotion 12% (Lac-Hydrin) and Halobetasol Propionate Ointment 0.05% (Ultravate) in the Treatment and Maintenance of Psoriasis.

Graduate Membership in Honorary/Professional Societies

• American Academy of Dermatology • American Society for Dermatologic Surgery • American Academy of Cosmetic Surgery • American Society for Laser Medicine and Surgery • American Society of Cosmetic Dermatology and Aesthetic Surgery • National Society for Cutaneous Medicine

Research Clinical Trials Investigator, The Menkes Clinic and Bay Area Laser Institute, Private Practice (January 2014 to present)

Principal Investigator (PI)

• Perioral Lines Device Study (fractional radiofrequency) – Syneron The safety and efficacy of the Syneron eTwo RF Sublative Device for perioral rejuvenation, wrinkle reduction, and textural improvement – Syneron Candela, 2014-2015.

Sub-Investigator (Sub-I)

• Pigmented Lesion Laser Study – Syneron Laser Treatment of Benign Pigmented Lesions With A Dual Wavelength Picosecond Laser. Protocol DHF13661. Syneron Candela, 2014-2015.

Clinical Trials Investigator, Mount Sinai School of Medicine, Department of Dermatology Clinical Trials Center (July 2008 to July 2013) Principal Investigator (PI)

• Rosacea Study (intradermal injection) – Investigator Initiated A Double-Blind, Placebo Controlled, Bilateral Comparison Study of the Safety and Efficacy of OnabotulinumtoxinA Versus Saline Injections in the Treatment of Rosacea of the Cheeks. Investigator Initiated Study, 2013-2014.

• Alopecia Areata Study (hair transplantation) – Investigator Initiated Efficacy of Hair Transplantation Compared with Hypodermic Needle Irritation in Alopecia Areata. Investigator Initiated Study, 2010-2012.

• Eyelash Enhancement Study (topical medication) – Athena A Double-Blind, Parallel Group, Randomized, Placebo-Controlled Study of the Cosmetic Efficacy and Safety of A Novel Eyelash Conditioner. Protocol RL-3D020.01 – Athena Cosmetics, 2011-2012.

• Plaque Psoriasis Study (subcutaneous + oral medication) – Stiefel A Randomized, Controlled Trial of Etanercept and Acitretin as Combination Therapy for Severe Plaque-Type Psoriasis. Stiefel, 2009-2010. • Atopic Dermatitis Study (topical medication) – Medicis Intermittent Application of Vanos® Cream (fluocinonide) 0.1% as a Maintenance Treatment to Prevent Relapse in Subjects with Atopic Dermatitis. Medicis, 2009- 2010. • Atopic Dermatitis Study (topical medication) – Ferndale Bilateral Comparison Study of Elidel® (pimecrolimus) Cream 1% and Eletone™ Cream in the Treatment of Patients with Atopic Dermatitis. Investigator Initiated, 2009-2010. • Atopic Dermatitis Study (topical medication) – Provectus

A Phase 2 Efficacy and Safety Study of PH-10 Aqueous Hydrogel for the Treatment of Atopic Dermatitis. Protocol PH-10-AD-21 – Provectus, 2009-2010.

• Plaque Psoriasis Study (topical medication) – Provectus A Phase 2 Efficacy and Safety Study of PH-10 Aqueous Hydrogel for the Treatment of Plaque Psoriasis. Protocol PH-10-PS-22 – Provectus Pharmaceuticals, 2009-2010.

• Plaque Psoriasis Study (topical medication) – Ranbaxy A Randomized, Double-Blind Study To Evaluate The Efficacy of Ammonium Lactate Lotion 12% (Lac-Hydrin) and Halobetasol Propionate Ointment 0.05% (Ultravate) in the Treatment and Maintenance of Psoriasis. Medicis 2009-2010.

Sub-Investigator (Sub-I)

• Periorbital Lines (topical medication) – Revance An Open Label Multi-Center Study to Assess the Long-Term Safety of Repeat Administration of RT001 (Botulinum Toxin Type A) Topical Gel, for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults. Protocol RT001-CL023 – Revance, 2012-2014.

• Midface Volume and Countour Enhancement (intradermal injection) – Medicis A Randomized, Evaluator-Blinded, No-Treatment-Control Study of the Effectiveness And Safety of Perlane-L® in the Correction of Midface Volume Deficit and/or Midface Contour Deficiecy. Protocol MA-1400-05 – Medicis, 2012-2013.

• Lip and Periorbital Enhancement (intradermal injection) – Allergan A Multicenter, Double-Blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLBELLA™ XC Injectable Gel for Lip and Perioral Enhancement. Protocol VOLBELLA-004 – Allergan, 2013-2014.

• Crow’s Feet Lines and Glabellar Lines (intramuscular injection) – Allergan

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex in Subjects with Facial Rhytides (Crow’s Feet Lines and Glabellar Lines). Protocol 191622-099 – Allergan, 2011-2012.

• Plaque Psoriasis Study (subcutaneous injection) – Abbott

A Phase 3, Multi-center, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects with Moderate to Severe Chronic Plaque Psoriasis. Protocol M10-114 – Abbott, 2008-2009.

• Plaque Psoriasis Study (subcutaneous injection) – Abbott A Multicenter Open-Label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects who Completed a Preceding Psoriasis

Clinical Study with Adalimumab. Protocol M03-658 – Abbott, 2007- 2008.

• Plaque Psoriasis Study (subcutaneous injection) – Abbott A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects with Moderate to Severe Chronic Plaque Psoriasis. Protocol M06-890 – Abbott, 2007-2008. • Plaque Psoriasis Study (subcutaneous injection) – Abbott A Phase 3, Multicenter, Open Label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects who Completed a Preceding Psoriasis Study with ABT-874. Protocol M10-016 – Abbott, 2007-2008. • Plaque Psoriasis Study (subcutaneous injection) – Abbott Open-label Study of Adalimumab in Subjects who have a Sub-optimal Response to Systemic Therapy or Phototherapy. Protocol M10-238 – Abbott, 2007-2008. • Plaque Psoriasis Study (subcutaneous injection) – Centocor A Phase 3, Multi-center, Randomized, Double-Blind, Placebo-controlled Trial

Evaluating the Efficacy and Safety of Ustekinumab (CNTO 1275) in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis. Protocol C0743T08 – Centocor, 2007-2008.

• Plaque Psoriasis Study (subcutaneous injection) – Centocor A Phase 3, Multi-center, Randomized, Double-Blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of Ustekinumab (CNTO 1275) in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis. Protocol C0743T09 – Centocor, 2007-2008. • Plaque Psoriasis Study (subcutaneous/intravenous medication) – Wyeth An Ascending Multiple Dose Study of the Safety, Tolerability Pharmacokinetics, Pharmacodynamics and Clinical Efficacy of ILV-094 Administered Subcutaneously or Intravenously to Subjects with Psoriasis. Protocol 3199K2- 1105 – Wyeth, 2007-2008. • Plaque Psoriasis Study (topical medication) – Stiefel A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety and Efficacy of Emulsion Formulation Calcipotriene Foam, 0.005%, versus Vehicle Foam in Subjects with Plaque-type Psoriasis. Protocol U0267-301 – Stiefel, 2008. • Plaque Psoriasis Study (topical medication) – Galderma A Multi-Center, Open-Label Study to Evaluate the Safety and Efficacy of a Consecutive Treatment Regimen of Clobetasol Propionate 0.05% Spray,

Followed by Calcitriol Ointment 3µg/g, in the Management of Moderate to Severe Plaque Psoriasis. Protocol GLI.04.SPR.US10085 – Galderma, 2008. • Herpes Zoster Study (topical + oral medication) – aRigen Phase II/III Multicenter, Double-Blind, Controlled Trial Comparing topical ARYS-01 Cream (3% Sorivudine), Oral Valaciclovir, and combination Topical ARYS-01 Cream /Oral Valaciclovir for the Treatment of Herpes Zoster in Immunocompetent Patients 18 Years of Age or Older. Protocol ARYS-0701 – aRigen, 2008. • Actinic Keratosis Study (topical medication) – Actavis A Multicenter, Double-Blind, Randomized, Parallel-Group Vehicle- Controlled Study to Determine the Clinical Equivalence of a Generic Imiquimod Cream, 5% and AldaraTM Cream in Subjects with Actinic Keratosis. Protocol D94-3101-07 – Actavis, 2007-2008 • Nasolabial Fold Study (injectable medication) – Bioform Medical Protocol for the evaluation of pain with the use of lidocaine-mixed Radiesse for the treatment of nasolabial folds. Protocol PO408329 - Bioform Medical, 2008-2009.

• Pityriasis Rubra Pilaris Study (subcutaneous injection) – Astellas A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris. Astellas 2008-2009. • Plaque Psoriasis Study (subcutaneous injection) – NovoNordisk Randomized, double-blind, placebo-controlled, single dose and multiple dose- escalation study to assess the safety and tolerability of Anti IL-20 in a phase 1/2a trial of patients with moderate-to-severe stable plaque psoriasis. Protocol NN8226-1848. Novo Nordisk 2009-2010. • Hand Eczema Study (oral medication) – Basilea Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy. Protocol BAP01346 – Basilea, 2009-2010. • Skin Cancer Study (oral medication) – Genentech A Pivotal Phase II, Multicenter, Single-Arm, Two-Cohort Trial Evaluating The

Efficacy and Safety of GDC-0449 In Patients With Advanced Basal Cell Carcinoma. Protocol SHH4476g – Genentech, 2009-2010.

• Skin Cancer Study (photodynamic therapy + topical medication) – DUSA A Randomized, Evaluator-Blinded, Parallel Group Comparison of Photodynamic Therapy With Levulan® Topical Solution + Blue Light Versus Levulan® Topical Solution Vehicle + Blue Light For The Treatment Of Actinic Keratosis And Reduction Of New Non-Melanoma Skin Cancer On The Scalp Or Both Forearms

In Organ Transplant Recipients. Protocol DUSA-CP0104 - DUSA Pharmaceuticals, 2009-2010. • Actinic Keratosis Study (cryotherapy + topical medication) – Graceway A Phase 3b, Randomized, Double-Blinded, Placebo-controlled, Multicenter, Efficacy and Safety Study of Imiquimod Cream Following Cryosurgery for the Treatment of Actinic Keratoses. Protocol GW01-0901 - Graceway Pharmaceuticals, 2009-2010.

• Actinic Keratosis Study (topical medication) – Peplin

A multi-center, Randomized, parallel group, double-blind, vehicle-controlled study to evaluate the Efficacy and safety of PEP005 (ingenol mebutate) Gel, 0.015% In patients with actinic keratoses ON the head (face or scalp) (REGION- IIb). Peplin PEP005-025 – Peplin, 2009-2010.

• Pyoderma Gangrenosum Study (oral medication) – Celgene A Pilot Study to Evaluate the Safety and Efficacy of CC-10004 in the Treatment of Pyoderma Gangrenosum. Protocol AP0028 – Celgene Corporation, 2009- 2010.

• Rosacea Study (pulse dye laser + topical medication) – Investigator Initiated Combination Therapy for the Treatment of Erythematotelangiectatic Rosacea. Investigator Initiated, 2009-2010. • Verruca Study (photodynamic therapy) – DUSA Prospective, randomized, double-blind study using 20% ALA-photodynamic therapy (ALA-PDT) for treatment of warts on the dorsum of fingers, including periungual warts. Investigator Initiated, 2009-2010. • Atopic Dermatitis Study (topical medication) – Onset Therapeutics

Bilateral Comparison Study of Elidel® (pimecrolimus) Cream 1% and Hylatopic™ Emollient Foam in the Treatment of Subjects with Atopic Dermatitis. Investigator Initiated, 2010-11.

• Plaque Psoriasis Study (oral medication) – VBL Therapeutics A Randomized, Double-Blind, 12-Week, Dose-Ranging, Placebo-Controlled Study to Evaluate (1) the Efficacy and Safety of Oral VB-201 in Patients with Moderate to Severe Plaque Psoriasis and (2) the Effect of Oral VB-201 on Carotid Artery and Ascending Aorta PET 18FDG Uptake in Psoriasis Patients with Abnormal Baseline PET 18FDG Scans. Protocol VB-201-006-C – VBL Therapeutics, 2010-2011. Oral Presentations Emer J. The Use of a Blunt-Tip Microcannula for Injection of a Hyaluronic Acid Soft Tissue Filler in the Treatment of Neck Laxity/Wrinkling. Cosmetic Surgery Forum, Aria Resort and Casino, Las Vegas, NV, Dec 5-7, 2013.

Emer J. Neutrophilic Dermatoses – What? Why? How? Presented at Elmhurst Hospital Grand Rounds, Elmhurst, New York, Mar 30, 2012. Emer J. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Ammonium Lactate Lotion 12% (Lac-Hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis. Presented at the Dermatologic Society of Greater New York – Resident Night, Jan 26, 2012. Emer J. Liposculpture in Dermatology Residency Training. Presented at the Cosmetic Surgery Forum, Palazzo Hotel Resort and Casino, Las vegas, Nevada, Dec 1-4, 2011. Emer J. Bilateral Comparison Study of Elidel® (pimecrolimus) Cream 1% and Eletone™ Cream in the Treatment of Patients with Atopic Dermatitis. Presented at the Winter Clinical Dermatology Conference, Mauna Lani Resort, Kohala Coast, Hawaii, Jan 14-19, 2011. Emer J. Bilateral Comparison Study of Elidel® (pimecrolimus) Cream 1% and Eletone™ Cream in the Treatment of Patients with Atopic Dermatitis. Presented at the Cosmetic Surgery Forum 2010, Las Vegas, Nevada, Dec 2-4, 2010. Emer J. Immunology and Psoriasis: Past, Present, and Future Trends. Presented at the educational evening at the Department of Dermatology at New York Medical College/Metropolitan Hospital Center, New York, New York, Oct 12, 2010. Emer J, Fernandes N, Mercer S, Lebwohl M. Asymptomatic Abnormal Pigmentation. Presented at the Alabama Dermatologic Society Meeting at the Mount Sinai School of Medicine, New York, New York, May 29, 2010. Emer J, Whang T, Uliasz A, Lebwohl M. Thickened and Crusted Palms and Soles. Presented at the Alabama Dermatologic Society Meeting at the Mount Sinai School of Medicine, New York, New York, May 29, 2010. Marmur M, Emer J, Frankel A, Lee A, Milidiu L. Combination Therapy for the Non-Surgical Treatment of Skin Cancers: Latest Research. 42nd Mohs College Annual Meeting, New York, April 30-May 3, 2010. Emer J. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Ammonium Lactate Lotion 12% (Lac-Hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis. Presented at the Winter Clinical Dermatology Conference, Grand Hyatt Kauai, Hawaii, Jan 23-28, 2010. Emer J. The Evaluation of Pain with the Use of Lidocaine-Mixed Radiesse for the Treatment of Nasolabial Folds. Presented at the Cosmetic Surgery Forum 2009 in Las Vegas, Nevada, Dec 4-6, 2009. Emer JJ, Syed A. Tako-tsubo Cardiomyopathy. Presented at the American College of Physicians Scientific Meeting at the University of Chicago, Illinois, Nov 2007.

Poster Presentations Emer J. The Use of a Blunt-Tip Microcannula for Injection of a Hyaluronic Acid Soft Tissue Filler in the Treatment of Neck Laxity/Wrinkling. Cosmetic Surgery Forum, Aria Resort and Casino, Las Vegas, NV, Dec 5-7, 2013. Emer J, Gropper J, Goldstein N, Waldorf H. Improvement in Lupus Pernio with the Successive Use of Pulsed Dye Laser and Non-ablative Fractional Resurfacing. Skin of Color Seminar Series, Crowne Plaza Times Square, New York, NY, May 4-5, 2013. Emer J, Goldstein N, Waldorf H. Combining soft tissue fillers on the same-day treatment for severe facial wasting (HIV lipoatrophy). Skin of Color Seminar Series, Crowne Plaza Times Square, New York, NY, May 4-5, 2013. Emer J, Goldstein N, Waldorf H. The use of a blunt-tipped cannula for injection of hyaluronic acid soft tissue filler in the treatment of linear scleroderma/en coup de sabre. Skin of Color Seminar Series, Crowne Plaza Times Square, New York, NY, May 4-5, 2013. Emer J, Goldstein N, Waldorf H. Combining soft tissue fillers on the same-day treatment for severe facial wasting (HIV lipoatrophy). Orlando Dermatology Aesthetic and Clinical Conference (ODAC), Omni Orlando Resort at Champions Gate, Orlando, FL, Jan 18-21, 2013. Emer J, Goldstein N, Waldorf H. The use of a blunt-tipped cannula for injection of hyaluronic acid soft tissue filler in the treatment of linear scleroderma/en coup de sabre. Orlando Dermatology Aesthetic and Clinical Conference (ODAC), Omni Orlando Resort at Champions Gate, Orlando, FL, Jan 18-21, 2013. Emer J, Levy L, Roberts D, Sidhu H, Fernandez N. Silicone Granulomas of the Buttocks Treated with Minocycline. American Society for Dermatologic Surgery (ASDS) Annual Meeting, Atlanta, Georgia, Oct 11-14, 2012. Gropper J, Emer J, Levitt J. A Case of Lymphangioma Circumscriptum Successfully Treated with Electrodessication Following Failure of Pulsed Dye Laser. Skin of Color Conference, Crowne Plaza Times Square, New York, New York, Apr 14, 2012. Levy L, Emer J. The Use of Camouflage Makeup for Facial Skin Conditions - Broadening Our Therapeutic Options. Orlando Dermatology Aesthetic and Clinical Conference, Orlando, Florida, Jan 13-19, 2012. Emer J. Liposculpture in Dermatology Residency Training. Cosmetic Surgery Forum, Palazzo Hotel Resort and Casino, Las Vegas, Nevada, Dec 1-4, 2011. Henry M, Frankel A, Emer J, Lebwohl M. Bilateral comparison study on the order of application of combination clobetasol proprionate spray and calcitriol ointment in the

treatment of plaque psoriasis. American Academy of Dermatology 2011 Annual Meeting, New Orleans, Louisiana, Feb 2-8, 2011. P3343. Emer J, Frankel A, Sohn A, Lebwohl M. A randomized, double-blind, placebo-controlled study to evaluate the efficacy of ammonium lactate lotion 12% and halobetasol propionate ointment 0.05% in the treatment and maintenance of psoriasis. American Academy of Dermatology 2011 Annual Meeting, New Orleans, Louisiana, Feb 2-8, 2011. P3323. Frankel A, Sohn A, Emer J, Lebwohl M. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid based emollient foam in the treatment of patients with atopic dermatitis. American Academy of Dermatology 2011 Annual Meeting, New Orleans, Louisiana, Feb 2-8, 2011. P1314. Penrose C, Marmur E, Emer J, Phelps R. Axillary sweating decreased by laser hair removal with the diode 810-nm system. American Academy of Dermatology 2011 Annual Meeting, New Orleans, Louisiana, Feb 2-8, 2011. P3602. Frankel A, Emer J, Patel RV, Sohn A, Lebwohl M. Bilateral Comparison Study of Pimecrolimus Cream 1% and Ceramide-Hyaluronic Acid Emollient Foam in the Treatment of Subjects with Atopic Dermatitis. Winter Clinical Dermatology Conference, Mauna Lani Resort, Kohala Coast, Hawaii, Jan 14-19, 2011. Emer J, Frankel A, Sohn A, Lebwohl M. Bilateral Comparison Study of Elidel® (pimecrolimus) Cream 1% and Eletone™ Cream in the Treatment of Patients with Atopic Dermatitis. Fall Clinical Dermatology Conference, Encore Hotel, Las Vegas, October 8-11, 2010. Emer J, Frankel A, Lebwohl M. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Ammonium Lactate Lotion 12% (Lac-Hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis. Fall Clinical Dermatology Conference, Encore Hotel, Las Vegas, October 8-11, 2010. Emer J, Frankel A, Sohn A, Lebwohl M. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Ammonium Lactate Lotion 12% (Lac-Hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis. Mount Sinai School of Medicine GME Research Day, New York, New York, June 8th, 2010. Emer J, Frankel A, Sohn A, Lebwohl M. Bilateral Comparison Study of Elidel® (pimecrolimus) Cream 1% and Eletone™ Cream in the Treatment of Patients with Atopic Dermatitis. Winter Clinical Dermatology Conference, Grand Hyatt Kauai, Hawaii, Jan 23-28, 2010. Emer J, Frankel A, Lebwohl M. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Ammonium Lactate Lotion 12% (Lac-Hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance

of Psoriasis. Winter Clinical Dermatology Conference, Grand Hyatt Kauai, Hawaii, Jan 23-28, 2010. Frankel A, Emer JJ, Lebwohl M. A Randomized, Double-Blind Study to Evaluate the Efficacy of Ammonium Lactate Lotion 12% (Lac-Hydrin) and Halobetasol Propionate Ointment 0.05% (Ultravate) in the Treatment and Maintenance of Psoriasis. Fall Clinical Dermatology Conference, Wynn Resort Hotel and Casino, Las Vegas, Nevada, Oct 15-18, 2009. Emer JJ, Lebwohl MG. A Case Report: A Bilateral Comparison Study of Pimecrolimus 1% Cream and a Hydrolipid Device Cream for the Treatment of Atopic Dermatitis. Winter Clinical Dermatology Conference, Hawaii, Jan 16-20, 2009. Emer JJ. Calciphylaxis. American College of Physicians Scientific Meeting at the University of Chicago, Illinois, November 2007. Publications Parrish S, Yao J, Emer J, Levitt J. Pulsed Dye Laser For Pigmented Purpura. Status: Submitted JAAD. Doktor V, Emer J. Update on the management of Rosacea. Status: Accepted to Clinical, Cosmetic and Investigational Dermatology. Sivek R, Emer J. The Use of Blunt-tipped Microcannula for Soft Tissue Filler Injection in the Treatment of Linear Scleroderma (En Coup De Sabre). Status: Accepted to Dermatologic Surgery Journal. Emer J, Sundaram H. Aesthetic applications of calcium hydroxylapatite volumizing filler: an evidence-based review and discussion of current concepts: (part 2 of 2). Status: Accepted to Journal of Drugs and Dermatology. Emer J, Sundaram H. Aesthetic applications of calcium hydroxylapatite volumizing filler: an evidence-based review and discussion of current concepts: (part 1 of 2). J Drugs Dermatol. 2013 Dec 1;12(12):1345-54. Emer J, Uslu U, Waldorf H. Improvement in Lupus Pernio with the Successive Use of Pulsed Dye Laser and Nonablative Fractional Resurfacing. Dermatol Surg. 2013 Nov 14. Emer J, Luber A, Gropper J, Sidhu H, Phelps R. A patch of hair loss on the scalp. J Clin Aesthet Dermatol. 2013 Jul;6(7):45-9. Emer J, Pandey S, Marciniak BJ, Sidhu H, Phelps R. Hyperpigmented follicular papules and bullae in an immunocompromised infant. J Clin Aesthet Dermatol. 2014 Jan;7(1):44-7. Levy LL, Emer JJ. Female pattern alopecia: current perspectives. Int J Womens Health. 2013 Aug 29;5:541-556.

Emer J, Luber A, Yazdani M, Marciniak B, Sidhu H, Phelps R. Neonate with annular plaques of the scalp. J Clin Aesthet Dermatol. 2013 Jun;6(6):43-7. Harcharik S, Emer J. Steroid-Sparing Properties of Emollients in Dermatology. Accepted: Skin Therapy Letter. Emer J, Pacific K, Marciniak B, Sidhu H, Phelps R. Crusted papules in a linear distribution on the leg of an adult woman. J Clin Aesthet Dermatol. 2013 Jan;6(1):47–50. Rhee L, Gropper C, Sidhu H, Emer J. An expanding serpiginous plaque of the lower extremity. J Clin Aesthet Dermatol. 2012 Dec;5(12):46–8. Levy LL, Emer JJ. Emotional benefit of cosmetic camouflage in the treatment of facial skin conditions: personal experience and review. Clin Cosmet Investig Dermatol. 2012;5:173–82. Emer J, George DD, Bernardo S, Sidhu H. Shiny white patches of the arms and forehead. J Clin Aesthet Dermatol. 2013 Aug;6(8):39-46. Al-Mozan N, Heinecke G, Pompei D, Emer J. Vesicular and verrucous hemorrhagic plaque in a young adolescent girl. J Clin Aesthet Dermatol. 2012 Nov;5(11):49–C3. Emer JJ, Bernardo SG, Kovalerchik O, Ahmad M. Urticaria multiforme. J Clin Aesthet Dermatol. 2013 Mar;6(3):34–9. Emer J, Pan M, Bernardo S, Sidhu H. A young boy with itchy papules on the trunk. J Clin Aesthet Dermatol. 2013 Apr;6(4):43–5. Levy LL, Solomon SM, Emer JJ. Biologics in the Treatment of Psoriasis and Emerging New Thearapies in the Pipeline. Psoriasis: Targets and Therapy. 2012 June 18;2:29–43. Emer J, Roberts D, Levy L, Sidhu H, Fernandez N. Indurated plaques and nodules on the buttocks of a young healthy female. J Clin Aesthet Dermatol. 2013 Mar;6(3):46–9. Levy L, Emer J. Complications of Minimally Invasive Cosmetic Procedures: Prevention and Management. J Cut Aesthet Surg. 2012 Sep;5(2): 121-32. Bloom BS, Emer J, Goldberg DJ. Assessment of safety and efficacy of a bipolar fractionated radiofrequency device in the treatment of photodamaged skin. J Cosmet Laser Ther. 2012 Oct;14(5):208–11. Roberts D, Sidhu H, Phelps R, Goodheart H, Emer J. Generalized Anetoderma in the Setting of Secondary Syphilis: A Case Report and Review of the Literature. Status: Accepted to Journal of Clinical and Aesthetic Dermatology.

Weiss D, Lakdawala N, Sidhu H, Phelps R, Emer J. Pruritic annular patches with eosinophilia. J Clin Aesthet Dermatol. 2012 Aug;5(8):47–9. Emer J, Heinecke G, Sidhu H, Phelps B. Acute Painful Nodules in a Healthy Adult. J Clin Aesthet Dermatol. 2012 Oct;5(10):47–50. Bernardo S, Burnett M, Emer J, Gordon M. Hypertrophic Osteoarthropathy Presenting as Unilateral Cellulitis With Successful Treatment Using Pamidronate Disodum: A Case Report and Review of the Literature. J Clin Aesthet Dermatol. 2012;5(9):37–46. Emer J, Gropper J, Gallitano S, Levitt J. A case of lymphangioma circumscriptum successfully treated with electrodessication following failure of pulsed dye laser. Dermatol Online J. 2013 Mar 15;19(3):2. Robins P, Battle EF Jr, Alexis AF, Cook-Bolden F, Alqubaisy Y, McLeod MP, Nouri K, Saedi N, Chan HH, Dover JS, Vachiramon V, McMichael AJ, Emer JJ, Heath CR, Taylor SC, Zeichner J. Unique laser techniques in patients with skin of color. J Drugs Dermatol. 2011 Dec 1;10(12):4-26. Emer J. Best Practices and Evidenced-Based Use of the 800 nm Diode Laser for the Treatment of Pseudofolliculitis Barbae in Skin of Color. J Drugs Dermatol. 2011 Dec 1;10(12):s20–22. Emer J, Waldorf H. Botox and Filler: There Is No Free Lunch. Clin Dermatol. 2011 Nov;29(6):678–90. Gleason G, Emer J, Larian A. The Treatment of Nail Psoriasis: A Review. Accepted: Psoriasis Forum. Sundaram H, Emer J. Natural Therapies for Hyperpigmentation. J Drugs Dermatol. 2011 Sep 1; 10(9):s15–20. Emer JJ. Liposculpture versus liposuction: is there a trend towards body contouring rather than traditional fat removal? Plastic Surgery Practice. Oct 2011 issue; pages 22– 25. Emer JJ, Soloman S, Mercer SE. Reed’s Syndrome: A Case of Multiple Cutaneous and Uterine Leiomyomas. J Clin Aesthet Dermatol. 2011 Dec;4(12):3–42. Emer JJ, Frankel A, Sohn A, Lebwohl M. A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis. J Drugs Dermatol. 2011 Jul 1;10(7):735–43. Larian A, Emer JJ, Gordon K, Blum R, Okun M, Gu Y, Lebwohl M. Efficacy and Safety of a Second Adalimumab Treatment Cycle in Psoriasis Patients Who Relapsed After Adalimumab Discontinuation or Dosage Reduction: A Double-Blind, Randomized, Placebo-Controlled Trial. Summer 2011, Vol 17, No. 2 issue of Psoriasis Forum.

Emer J, Waldorf H, Berson D. Botanicals and anti-inflammatories: natural ingredients for rosacea. Semin Cutan Med Surg. 2011 Sep;30(3):148–55. Roosevelt L, Emer J. Pustular Psoriasis: A Practical Review of the Literature. Psoriasis Forum. Spring 2011, Vol. 17, No.1. Pages 33–41. Henry M, Frankel A, Emer J, Lebwohl M. Psoriasis: Importance of Order of Application in Topical Therapy. Submitted Journal of Drugs and Dermatology. Englander L, Emer J, McClain D, Amin B, Turner R. A Rare Case of Multiple Segmental Eccrine Spiradenomas. J Clin Aesthet Dermatol. 2011 Apr;4(4):38–44. Emer J, Stevenson M, Markowitz O. The Novel Treatment of Female-Pattern Androgenetic Alopecia with Injected Bimatoprost 0.03% Solution. J Drugs Dermatol. 2011 Jul;10(7):795–8. Emer J, Frankel A, Sohn A, Lebwohl M. A Bilateral Comparison Study of Pimecrolimus Cream 1% and a Topical Medical Device Cream in the Treatment of Patients with Atopic Dermatitis. J Drugs Dermatol. 2011 Jul 1;10(7):795–8. Emer J, Frankel A, Sohn A, Lebwohl M. A Randomized, Double-blind, Placebol-controlled Study to Evaluate the Safety and Efficacy of Ammonium Lactate Lotion 12% and Halobetasol Propionate Ointment 0.05% in the Treatment and Maintenance of Psoriasis. J Clin Aesthet Dermatol. 2011;4(2):28–39 Emer J, Markowitz O. Trends in the treatment and detection of skin cancer. J Drugs Dermatol. 2011 Jan;10(1):16–8. Emer J, Waldorf H. Neurotoxin Update and Review: Part 2 – The Art. Cosmet Dermatol. 2010;23:474–480. Emer J, Waldorf H. Neurotoxin Update and Review: Part 1 – The Science. Cosmet Dermatol. 2010;23:413–418. Turner RB, Emer JJ, Weill M, Winterfield L, Friedman S, Qureshi AA. Rapid resolution of pyoderma gangrenosum after treatment with intravenous cyclosporine. J Am Acad Dermatol. 2010 Sep;63(3):e72–4. Kling MC, Larian AA, Scordi-Bello I, Emer J, Lebwohl M. Fatal Influenza A(H1N1) Respiratory Tract Infection in a Patient Having Psoriasis Treated With Infliximab. Arch Dermatol. 2010;146(6):651–654. Mortel MR, Emer J. Prospective New Biologic Therapies for Psoriasis and Psoriatic Arthritis. J Drugs Dermatol. 2010 Aug;9(8):947–58.

Koutruba N, Emer J, Lebwohl M. Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis. Ther Clin Risk Manag. 2010 Apr 15;6:123–41. Frankel A, Penrose C, Emer J. Cutaneous Tuberculosis: A Practical Case Report and Review for the Dermatologist. J Clin Aesthetic Dermatol. 2009;2(10):19–27. Marmur E, Emer J. Filler complications in skin of color. Expert Opinion for DermQuest®.com (http://www.dermquest.com/expert_opinions/surgery__cosmetics/filler_complications_in_skin_of_color.html); August 2009. Emer JJ, Wolinsky C. Rituximab: A Review of Dermatologic Applications. J Clin Aesthetic Dermatol. 2009;2(5):29–37. Emer JJ, Frankel A, Zeichner J. A Practical Approach To Monitoring Patients on Biological Therapies for Psoriasis. J Clin Aesthetic Dermatol. 2010;3(8):20–26 Levitt J, Emer JJ, Emanuel PO. Treatment of Porokeratosis of Mibelli with Combinational Use of Photodynamic Therapy and 5-Fluorouracil Cream. Arch Dermatol. 2010 Apr;146(4):371–3. Emer JJ. Is there a potential role for anti-TNF therapy in patients with Human Immunodeficiency Virus (HIV)? J Clin Aesthetic Dermatol. 2009;2(4):29–35. Emer J, Spear J. Primary Cutaneous Blastomycosis as a Cause of Acute Respiratory Distress Syndrome. J Clin Aesthetic Dermatol. 2009;2(3):22–30. Hernandez C, Emer JJ, Robinson JK. Perioperative Management of Medications for Psoriasis and Psoriatic Arthritis: A Review for the Dermasurgeon. Dermatol Surg 2008; 34:446–459. Toriumi DM, Hecht DA, Emer JJ. Skeletal Modifications in Rhinoplasty. Facial Plast Surg 2000;8:413-431. Book Chapters Emer J, Waldorf H. Cannulas for Soft Tissue Augmentation. In Procedural Dermatology, edited by Avram, Avram and Ratner. (IN PRESS) Emer J, Waldorf H. Non-Hyaluronic Acid Fillers. In Illustrated Textbook of Cosmetic Dermatology, edited by Dr. Jaishree Sharad (IN PRESS). Pacific K, Emer J. Reed Syndrome. In Acneiform Eruptions in Dermatology: A Differential Diagnosis, edited by Dr. Joshua Zeicher. (Chapter 32, pp. 221-228).

Emer J, Waldorf H. Soy and Oatmeal Based Cosmeceuticals. In Cosmeceuticals and Cosmetic Practice. 1st Edition. Edited by Dr. Patricia Farris. Wiley & Sons, Ltd. 2014. (Chapter 13, pp. 133-141). Patel RV, Goldenberg G. Awk Emer J. Drug Eruptions, chapter 3. In Buka’s Emergencies in Dermatology. 1st Edition. Editied by Bobby Buka, Annemarie Uliaz, Karthik Krishnamurthy. (pp. 44-55) Emer J, Waldorf H. Squamous Cell Carcinoma, chapter 222. In Treatment of Skin Disease: Comprehensive Therapeutic Strategies, 4th Edition. Lebwohl MG, Leymann WR, Berth-Jones J, Coulson I (eds.) Elsiver Limited/Saunders, 2014. (pp. 718-723) Emer J, Khorasani H. Striae, chapter 226. In Treatment of Skin Disease: Comprehensive Therapeutic Strategies, 4th Edition. Lebwohl MG, Leymann WR, Berth-Jones J, Coulson I (eds.) Elsiver Limited/Saunders, 2014. (pp. 730-733) Emer JJ, Larian A, Lebwohl M. Interleukin12/23 Inhibitors. In Wolverton SW, Comprehensive Dermatologic Drug Therapy. 3rd edition. Saunders. 2013. (pp. 319-332) Emer J, Marmur E, Waldorf H. Botulinum Toxin. Botulinum Toxins in Dermatology: Cosmetic and Clinical Applications, ed. Joel Cohen. (IN PRESS) Emer J, Waldorf H, and Cohen J. Complications and their management: ch. 12 in Sadick NS, Carniol PJ, Roy D, and Wiest L (eds), Illustrated Manual of Injectable Fillers: A Technical Guide to the Volumetric Approach to Whole Body Rejuvenation, Informa Healthcare: London and New York, 2011. Emer J, Lebwohl MG. Combinational, Rotational, and Sequential Therapy. Moderate-to-Severe Psoriasis, Third Edition. Ed. JY Koo, CS Lee, MG Lebwohl, GD Weinstein, A Gottlieb. Informa HealthCare, New York, NY. 2008. (pp. 193-217). Toriumi DM, Hecht DA, Emer JJ. External Rhinoplasty Approach. Head and Neck Surgery Otolaryngology, Volume 2, Third Edition. Lippencott, Williams, & Wilkins, Philadelphia, PA. 2001. (pp. 2241-2253). Reviewer Laser Therapy for the Treatment of Hailey-Hailey Disease: A Systematic Review. Reviewed August 4, 2014 for Journal of the European Academy of Dermatology and Venereology. Hyaluronic acid incidentally found during Mohs surgery: 16 cases from a single surgical center, 2003-2013. Reviewed July 9, 2014 for JAMA Dermatology. Efficacy and safety of topical adenosine for androgenetic alopecia: a double-blind, randomized clinical trial. Reviewed June 10, 2014 for the Archives of Dermatological Research.

Rapidly growing periorbital lesion in a patient with Favre-Racouchot syndrome. Reviewed May 30, 2014 for the Journal of Clinical and Aesthetic Dermatology (JCAD). Minimally invasive Procedures for Facial Rejuvenation. Reviewed April 12, 2014 for OMIC Group Incorporation Open Acess eBooks. Evaluating the success of Nd: YAG Laser Ablation in the Treatment of Recalcitrant Verruca Plantaris and a Cautionary Note about Local Anaesthesia on the Plantar Aspect of the Foot. Reviewed March 3, 2014 for the Journal of European Academy of Dermatology Venereology. Draining Dermal Nodules on the Lower Extremity. Reviewed January 31, 2014 for The Journal of Clinical and Aesthetic Dermatology. A Linear Pruritic Eruption following Allergic Contact Dermatitis. Reviewed December 18, 2013 for The Journal of Clinical and Aesthetic Dermatology. Preparation and Evaluation of Combined Minoxidil Multimodal Microemulsion Vs Minoxidil in the Treatment of Androgenetic Alopecia with Mixed Etiology: A Pilot study. Reviewed February 10, 2013 for Journal of Drug Design, Development and Therapy. Recent Trend in the Choice of Fillers and Injection Techniques in Asia: A Questionnaire Study Based on Expert Opinion. Reviewed December 19, 2012 for Journal of European Academy of Dermatology Venereology. Halobetasol propionate 0.05% cream: a guide to its use in the treatment of plaque psoriasis. Reviewed November 9, 2012 for Drugs and Therapy Perspectives. Primary hypertrophic osteoarthropathy: an update. Reviewed November 30, 2012 for Frontiers of Medicine. Rituximab for the Treatment of Pemphigus Vulgaris: A Disease Focused Case Series. Reviewed July 10, 2012 for Journal of the European Academy of Dermatology and Venereology. Emerging technologies for the detection of melanoma: achieving better outcomes. Reviewed June 4, 2012 for Journal of Clinical, Cosmetic and Investigational Dermatology. Treatment and cosmetic outcome of curettage and pulsed CO2 laser for basal cell carcinoma. Reviewed May 28, 2012 for Journal of Skin Cancer. Patient specific diagnosis and treatment intervention in the management of metastatic melanoma. Reviewed May 16,, 2012 for Pharmacogenomics and Personalized Medicine (Dove press open access). Treatment of multiple scrotal cysts with a 910 nm short-pulsed diode laser. Reviewed May 7, 2012 for the Journal of Cosmetic and Laser Therapy.

Objective and subjective in vivo comparison of two emollient products. Reviewed Apr 10, 2012 for Clinical, Cosmetic and Investigational Dermatology. (Dove press open access). Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramides hyaluronic acid emollient foam (Hylatopic Plus). Reviewed Dec 22, 2011 for Clinical, Cosmetic and Investigational Dermatology (Dove press open access). Biodermaceutical herbal formula for the treatment of chronic vulvar dermatitis: proposal for a new treatment scheme. Reviewed Mar 25, 2011 for the Journal of Drugs in Dermatology. Six patients with pyoderma gangrenosum successfully treated with infliximab. Reviewed Mar 18, 2011 for The International Journal of Dermatology. Etiology and Management of Pyoderma Gangrenosum: A Comprehensive Review. Reviewed Mar 13, 2011 for The American Journal of Clinical Dermatology. Microsponges: Manufacture, Use, and Clinical Benefits for Topical Drug Delivery. Reviewed Mar 13, 2011 for The Journal of Clinical and Aesthetic Dermatology. Palmoplantar Subcorneal Pustular Dermatosis (SPD) Following Adalimumab Therapy for Rheumatoid Arthritis. Reviewed Dec 13, 2010 for Journal of Cutaneous Medicine & Surgery. Biochemical and clinical effects of ω-3 fatty acid supplementation in psoriatic patients undergoing phototherapy. Reviewed Dec 6, 2010 for The Journal of the American Academy of Dermatology. Adalimumab plus Narrowband UltravioletB Light Phototherapy for the Treatment of Moderate to Severe Psoriasis. Reviewed Oct 23, 2010 for The Journal of Drugs in Dermatology. A Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy of a Citrus Bioflavanoid Blend in the Treatment of Senile Purpura. Reviewed Oct 18, 2010 for The Journal of Drugs in Dermatology. Results of a Treatment Strategy in Psoriasis Combining a Phosphorylase Kinase Inhibitor and Topical Steroids with Removal of Precipitating Factors: A Large Case Series. Reviewed Oct 15, 2010 for The Journal of the American Academy of Dermatology. CME/Conference Attendance Cosmetic Bootcamp, Saint Regis Aspen Resort, Aspen, Colorado, Jun 12-14, 2014. THE Aesthetic Show 2014 – Advanced Dermal Filler Techniques, The Four Seasons Hotel, San Francisco, California, Feb 15-17, 2014.

Cosmetic Surgery Forum, Aria Resort and Casino, Las Vegas, Nevada, Dec 5-7, 2013. American Society for Dermatologic Surgery (ASDS) Annual Meeting, Hyatt Regency Hotel, Chicago, Illinois, Oct 3-6, 2013. 2nd Annual Advances in Facial and Reconstruction and Cosmetic Surgery, Mount Sinai School of Medicine, New York, New York, Jun 1-2, 2013. 4th Annual Skin of Color Seminar Series, Crowne Plaza Times Square, New York, New York, May 4-5, 2013. Real World Dermatology Conference, Luxor Hotel, Las Vegas, Nevada, Apr 18-21, 2013. American Academy of Dermatology 2013 Annual Meeting, Miami Beach, Florida, Mar 1-5, 2013. 15th Annual Advances in Medical and Surgical Dermatology, Mount Sinai School of Medicine, New York, New York, Dec 7-9, 2012. American Society for Dermatologic Surgery (ASDS) Annual Meeting, Hyatt Regency Hotel, Atlanta, Georgia, Oct 11-14, 2012. Real Word Dermatology Conference, Flamingo Hotel, Las Vegas, Nevada, Jun 9-11, 2012. 3rd Annual Skin of Color Seminar Series, Crowne Plaza Times Square, New York, New York, Apr 14-15, 2012. Advances in Facial and Reconstruction and Cosmetic Surgery, Mount Sinai School of Medicine, New York, New York, Apr 14-15, 2012. American Academy of Dermatology 2012 Annual Meeting, San Diego, California, Mar 16-20, 2012. Winter Clinical Dermatology Conference, Hyatt Regency Maui, Hawaii, Jan14-19, 2012. 14th Annual Advances in Medical and Surgical Dermatology, Mount Sinai School of Medicine, New York, New York, Dec 9-11, 2011. Cosmetic Surgery Forum, Palazzo Hotel Resort and Casino, Las Vegas, Nevada, Dec 1-4, 2011. ASCDAS 2011 Annual Meeting, Exhibition and Workshops, Cosmopolitan Hotel, Las Vegas, Nevada, Dec 1-4, 2011.

New Frontiers in Cosmetic Medicine Symposium, Hackensack University Medical Center, Hackensack, New Jersey, Nov 19, 2011. Fall Clinical Dermatology Conference, Caesars Palace, Las Vegas, Nevada, Oct 27-30, 2011. National Psoriasis Foundation 13th Annular Chief Residents Meeting, Wyndham Hotel, Chicago, Illinois, Oct 14-16, 2011. Art and Science of Fillers and Injectables, New York, New York, Oct 15-16, 2011. Summer American Acacdemy Meeting of Dermatology 2011, New York, New York, Aug 3-7, 2011. 2nd Annual Skin of Color Seminar Series, Marriott Marquis, New York, New York, May 14, 2011. American Academy of Dermatology 2011 Annual Meeting, New Orleans, Louisiana, Feb 2-8, 2011. Winter Clinical Dermatology Conference, Mauna Lani Resort, Kohala Coast, Hawaii, Jan 14-19, 2011 13th Advances in Medical and Surgical Dermatology, Mount Sinai School of Medicine, New York, New York, Dec 10-12, 2010. Cosmetic Surgery Forum, Palazzo Hotel Resort and Casino, Las Vegas, Nevada, Dec 2-4, 2010. Fall Clinical Dermatology Conference, Encore Hotel, Las Vegas, Nevada, Oct 8-11, 2010. Alabama Dermatologic Society Meeting at the Mount Sinai School of Medicine, New York, New York, May 29, 2010. The Art and Science of Facial Injectables, Mount Sinai School of Medicine, New York, New York, May 15-16, 2010. American Academy of Dermatology 2010 Annual Meeting, Miami Beach, Florida, Mar 5-10, 2010. Winter Clinical Dermatology Conference, Grand Hyatt Kauai, Hawaii, Jan 23-28, 2010. 12th Annual Advances in Medical and Surgical Dermatology, Mount Sinai School of Medicine, New York, New York, Dec 9-11, 2009. Cosmetic Surgery Forum, Palazzo Hotel Resort and Casino, Las Vegas, Nevada, Dec 4-6, 2009.

American Academy of Dermatology 2010 Annual Meeting, San Franscisco, California, Mar 6-10, 2009.